ETON PHARMACEUTICALS, INC. (ETON)
Eton Pharmaceuticals to Report Second Quarter 2026 Financial Results on Thursday, August 13, 2026
Eton Pharmaceuticals to Report Second Quarter 2026 Financial Results on Thursday, August 13, 2026
Procore Technologies, Inc. Announces Proposed Private Placement of $750.0 Million of Convertible Senior Notes
Brookfield Completes Acquisition of Oaktree
Disclosure of Interest/ Changes in Interest of Substantial Shareholder(s)/ Unitholder(s): Disclosure of Interest/Changes in Interest of Substantial Shareholder(s)/ Unitholder(s)
Register of shareholders, changes and share capital status - central report - exercise of employee warrants, conversion of BONDS (series 2) into shares
Southern Company announces offerings of $650 million in aggregate principal amount of Convertible Senior Notes due December 15, 2027 and $1.5 billion in aggregate principal amount of Convertible Senior Notes due September 15, 2029
Supernus Announces Second Quarter 2026 Financial Results
Mandatory Cash Dividend/ Distribution:
DarioHealth to Report Second Quarter 2026 Results on Tuesday, August 11, 2026
General Announcement: Monthly Return of Equity Issuer on Movements in Securities